This progressive lung disease transforms healthy tissue into stiff, scarred areas making breathing difficult. Learn the ...
Sportschosun (English) on MSN5d
Dry cough and shortness of breath persistent idiopathic pulmonary fibrosis, average survival time of only 3-5 yearsHowever, along with genetic factors, there is a possibility that environmental factors such as dust, smoking, and pollutants, ...
News-Medical.Net on MSN3d
Blocking Piezo2 may offer a new therapeutic approach for pulmonary fibrotic diseasesResearchers have found a potential new way to slow the progression of lung fibrosis and other fibrotic diseases by inhibiting ...
The Program for Pulmonary Fibrosis and Interstitial Lung Disease's mission is to provide state of the art evaluation and treatment for patients with interstitial lung diseases (ILD). The University of ...
BEACON-IPF is a 52-week, multinational, randomized, dose-ranging, double-blind, placebo-controlled trial evaluating bexotegrast at once-daily doses of 160 mg or 320 mg in patients with idiopathic ...
Hosted on MSN6mon
Trimetallic-based nanocarriers method shows promise for visualized idiopathic pulmonary fibrosis therapyMore information: Hongying Bao et al, Enzyme-like nanoparticle–engineered mesenchymal stem cell secreting HGF promotes visualized therapy for idiopathic pulmonary fibrosis in vivo, Science ...
The American College of Chest Physicians (CHEST), the PF Warriors, the Rare Disease Diversity Coalition (RDDC)-a program at the Black Woman's Health Imperative-and the National Association of ...
The Program for Pulmonary Fibrosis and Interstitial Lung Disease's mission is to provide state of the art evaluation and treatment for patients with interstitial lung diseases (ILD). The University of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback